🇺🇸 FDA
Patent

US 9290757

Protease screening methods and proteases identified thereby

granted A61KA61K38/00A61P

Quick answer

US patent 9290757 (Protease screening methods and proteases identified thereby) held by Catalyst Biosciences, Inc. expires Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Catalyst Biosciences, Inc.
Grant date
Tue Mar 22 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 17 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00, A61P, A61P1/00, A61P1/02